A Randomized study of nutritional support in patients with colorectal and gastric cancer

被引:60
作者
Persson, CR [1 ]
Johansson, BBK
Sjöden, PO
Glimelius, BLG
机构
[1] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75183 Uppsala, Sweden
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2002年 / 42卷 / 01期
关键词
D O I
10.1207/S15327914NC421_7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Involuntary weight loss is often seen among patients with gastrointestinal (GI) cancer. Weight loss may influence quality of life (QoL) and is a predictor of survival. The present study is an attempt to improve body weight development in GI cancer patients by individual support (IS), including nutritional measures. Patients were randomized in a 2 X 2 design between 1) IS; including nutritional support, 2) group rehabilitation (GR), 3) IS + GR (ISGR), or 4) standard care (SC). Data concerning dietary intake (24-h recalls), body weight, and QoL (EORTC-QLQ C-30) were collected over 2 yr for 67 patients with colorectal or gastric cancer, randomized to IS or ISGR. Data on weight and QoL were collected for 70 patients with the same diagnoses randomized to GR or SC. Despite a tendency to greater weight loss at inclusion, the IS + ISGR group managed to gain weight significantly more rapidly and to a greater extent than the GR + SC group. The differences became statistically significant at 12 and 24 mo (P < 0.05). Patients with weight loss at baseline increased their energy intake and weight more than those without weight loss. No differences were seen in QoL ratings between randomization groups, but there was a positive correlation between weight development and QoL and a negative correlation between fatigue and weight development. There was a numerical difference, not statistically significant (P = 0.3), indicating a shorter time of survival inpatients in the GR + SC group. IS, including nutritional support, leads to more rapid weight gain than SC in patients with newly diagnosed GI cancer.
引用
收藏
页码:48 / 58
页数:11
相关论文
共 31 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
BOZZETTI F, 1990, NUTRITION, V6, P371
[3]  
BRAGA M, 1990, NUTRITION, V6, P177
[4]  
Briefel RR, 1997, AM J CLIN NUTR, V65, P1203
[5]  
BUHL K, 1990, EUR J SURG ONCOL, V16, P404
[6]   The use of telephone interview methodology to obtain 24-hour dietary recalls [J].
Casey, PH ;
Goolsby, SLP ;
Lensing, SY ;
Perloff, BP ;
Bogle, ML .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1999, 99 (11) :1406-1411
[7]   PROGNOSTIC EFFECT OF WEIGHT-LOSS PRIOR TO CHEMOTHERAPY IN CANCER-PATIENTS [J].
DEWYS, WD ;
BEGG, C ;
LAVIN, PT ;
BAND, PR ;
BENNETT, JM ;
BERTINO, JR ;
COHEN, MH ;
DOUGLASS, HO ;
ENGSTROM, PF ;
EZDINLI, EZ ;
HORTON, J ;
JOHNSON, GJ ;
MOERTEL, CG ;
OKEN, MM ;
PERLIA, C ;
ROSENBAUM, C ;
SILVERSTEIN, MN ;
SKEEL, RT .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :491-497
[8]  
Dolecek Therese A., 1997, American Journal of Clinical Nutrition, V65, p196S, DOI 10.1093/ajcn/65.1.196S
[9]  
DUBOIS S, 1990, J AM DIET ASSOC, V90, P1680
[10]   A RANDOMIZED STUDY OF ORAL NUTRITIONAL SUPPORT VERSUS AD-LIB NUTRITIONAL INTAKE DURING CHEMOTHERAPY FOR ADVANCED COLORECTAL AND NON-SMALL-CELL LUNG-CANCER [J].
EVANS, WK ;
NIXON, DW ;
DALY, JM ;
ELLENBERG, SS ;
GARDNER, L ;
WOLFE, E ;
SHEPHERD, FA ;
FELD, R ;
GRALLA, R ;
FINE, S ;
KEMENY, N ;
JEEJEEBHOY, KN ;
HEYMSFIELD, S ;
HOFFMAN, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) :113-124